NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026

A Contract Award Notice
by NHS ENGLAND

Source
Find a Tender
Type
Framework ()
Duration
not specified
Value
£35M-£665M
Sector
MISCELLANEOUS
Published
21 Jul 2026
Delivery
not specified
Deadline
n/a

Related Terms

Location

Geochart for 1 buyers and 26 suppliers

1 buyer

24 suppliers

Description

NHS Branded Framework Agreement – Lot 1 - Tranche A for the North of England and Midlands & East. Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion for a further 24 months. Lot 2 - Natalizumab for London and South of England. The period of Framework Agreement: 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.

Lot Division

1
2

Award Detail

1 Accord (Devon)
  • Lot 1 - CM/PHR/25/5730/01 - NHS National Branded Tranche B - NOFE & MAE
  • Reference: 3
  • Value: £665,389,588 [share]
  • Awarded to group of suppliers.
2 Amgen (Cambridge)
  • Lot 1 - CM/PHR/25/5730/01 - NHS National Branded Tranche B - NOFE & MAE
  • Reference: 3
  • Value: £665,389,588 [share]
  • Awarded to group of suppliers.
3 Aventis Pharma (Reading)
  • Lot 1 - CM/PHR/25/5730/01 - NHS National Branded Tranche B - NOFE & MAE
  • Reference: 3
  • Value: £665,389,588 [share]
  • Awarded to group of suppliers.
4 Bayer (Reading)
  • Lot 1 - CM/PHR/25/5730/01 - NHS National Branded Tranche B - NOFE & MAE
  • Reference: 3
  • Value: £665,389,588 [share]
  • Awarded to group of suppliers.
5 Biogen Idec (Maidenhead)
  • Lot 1 - CM/PHR/25/5730/01 - NHS National Branded Tranche B - NOFE & MAE
  • Reference: 3
  • Value: £665,389,588 [share]
  • Awarded to group of suppliers.
6 Chugai Pharma (Chiswick)
  • Lot 1 - CM/PHR/25/5730/01 - NHS National Branded Tranche B - NOFE & MAE
  • Reference: 3
  • Value: £665,389,588 [share]
  • Awarded to group of suppliers.
7 CST Pharma (Walsall)
  • Lot 1 - CM/PHR/25/5730/01 - NHS National Branded Tranche B - NOFE & MAE
  • Reference: 3
  • Value: £665,389,588 [share]
  • Awarded to group of suppliers.
8 Eli Lilly (Basingstoke)
  • Lot 1 - CM/PHR/25/5730/01 - NHS National Branded Tranche B - NOFE & MAE
  • Reference: 3
  • Value: £665,389,588 [share]
  • Awarded to group of suppliers.
9 Gedeon Richter (London)
  • Lot 1 - CM/PHR/25/5730/01 - NHS National Branded Tranche B - NOFE & MAE
  • Reference: 3
  • Value: £665,389,588 [share]
  • Awarded to group of suppliers.
10 Glaxosmithkline (London)
  • Lot 1 - CM/PHR/25/5730/01 - NHS National Branded Tranche B - NOFE & MAE
  • Reference: 3
  • Value: £665,389,588 [share]
  • Awarded to group of suppliers.
11 Laboratories Juvise Pharmaceuticals (Villeurbanne)
  • Lot 1 - CM/PHR/25/5730/01 - NHS National Branded Tranche B - NOFE & MAE
  • Reference: 3
  • Value: £665,389,588 [share]
  • Awarded to group of suppliers.
12 Merck Serono (Feltham)
  • Lot 1 - CM/PHR/25/5730/01 - NHS National Branded Tranche B - NOFE & MAE
  • Reference: 3
  • Value: £665,389,588 [share]
  • Awarded to group of suppliers.
13 Milpharm (Uxbridge)
  • Lot 1 - CM/PHR/25/5730/01 - NHS National Branded Tranche B - NOFE & MAE
  • Reference: 3
  • Value: £665,389,588 [share]
  • Awarded to group of suppliers.
14 Napp Pharmaceuticals (Cambridge)
  • Lot 1 - CM/PHR/25/5730/01 - NHS National Branded Tranche B - NOFE & MAE
  • Reference: 3
  • Value: £665,389,588 [share]
  • Awarded to group of suppliers.
15 Novo Nordisk (Gatwick)
  • Lot 1 - CM/PHR/25/5730/01 - NHS National Branded Tranche B - NOFE & MAE
  • Reference: 3
  • Value: £665,389,588 [share]
  • Awarded to group of suppliers.
16 Orifarm (Hemel Hempstead)
  • Lot 1 - CM/PHR/25/5730/01 - NHS National Branded Tranche B - NOFE & MAE
  • Reference: 3
  • Value: £665,389,588 [share]
  • Awarded to group of suppliers.
17 Pfizer (Kent)
  • Lot 1 - CM/PHR/25/5730/01 - NHS National Branded Tranche B - NOFE & MAE
  • Reference: 3
  • Value: £665,389,588 [share]
  • Awarded to group of suppliers.
18 Pharmacosmos (Reading)
  • Lot 1 - CM/PHR/25/5730/01 - NHS National Branded Tranche B - NOFE & MAE
  • Reference: 3
  • Value: £665,389,588 [share]
  • Awarded to group of suppliers.
19 Roche Products (Welwyn Garden City)
  • Lot 1 - CM/PHR/25/5730/01 - NHS National Branded Tranche B - NOFE & MAE
  • Reference: 3
  • Value: £665,389,588 [share]
  • Awarded to group of suppliers.
20 Sandoz (Bracknell)
  • Lot 1 - CM/PHR/25/5730/01 - NHS National Branded Tranche B - NOFE & MAE
  • Reference: 3
  • Value: £665,389,588 [share]
  • Awarded to group of suppliers.
21 Teva (Castleford)
  • Lot 1 - CM/PHR/25/5730/01 - NHS National Branded Tranche B - NOFE & MAE
  • Reference: 3
  • Value: £665,389,588 [share]
  • Awarded to group of suppliers.
22 Thornton & Ross (Huddersfield)
  • Lot 1 - CM/PHR/25/5730/01 - NHS National Branded Tranche B - NOFE & MAE
  • Reference: 3
  • Value: £665,389,588 [share]
  • Awarded to group of suppliers.
23 Viatris UK Healthcare (Potters Bar)
  • Lot 1 - CM/PHR/25/5730/01 - NHS National Branded Tranche B - NOFE & MAE
  • Reference: 3
  • Value: £665,389,588 [share]
  • Awarded to group of suppliers.
24 Vifor Pharma (London)
  • Lot 1 - CM/PHR/25/5730/01 - NHS National Branded Tranche B - NOFE & MAE
  • Reference: 3
  • Value: £665,389,588 [share]
  • Awarded to group of suppliers.
25 Biogen Idec (Maidenhead)
  • Lot 2 - CM/PHR/25/5730/02 - Natalizumab for London and South of England
  • Reference: 4
  • Value: £35,312,548 [share]
  • Awarded to group of suppliers.
26 Sandoz (Bracknell)
  • Lot 2 - CM/PHR/25/5730/02 - Natalizumab for London and South of England
  • Reference: 4
  • Value: £35,312,548 [share]
  • Awarded to group of suppliers.

CPV Codes

  • None found

Indicators

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

  • ocds-h6vhtk-051c98
  • FTS 068603-2026

Domains